121 related articles for article (PubMed ID: 20055894)
1. Lithocholic acid downregulates vitamin D effects in human osteoblasts.
Ruiz-Gaspà S; Guañabens N; Enjuanes A; Peris P; Martinez-Ferrer A; de Osaba MJ; Gonzalez B; Alvarez L; Monegal A; Combalia A; Parés A
Eur J Clin Invest; 2010 Jan; 40(1):25-34. PubMed ID: 20055894
[TBL] [Abstract][Full Text] [Related]
2. Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases.
Ruiz-Gaspà S; Guañabens N; Jurado S; Dubreuil M; Combalia A; Peris P; Monegal A; Parés A
Gene; 2020 Jan; 725():144167. PubMed ID: 31639434
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells.
Dubreuil M; Ruiz-Gaspà S; Guañabens N; Peris P; Alvarez L; Monegal A; Combalia A; Parés A
Liver Int; 2013 Aug; 33(7):1029-38. PubMed ID: 23560764
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis.
Ruiz-Gaspà S; Dubreuil M; Guañabens N; Combalia A; Peris P; Monegal A; Parés A
Eur J Clin Invest; 2014 Dec; 44(12):1206-14. PubMed ID: 25331234
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3.
Atkins GJ; Anderson PH; Findlay DM; Welldon KJ; Vincent C; Zannettino AC; O'Loughlin PD; Morris HA
Bone; 2007 Jun; 40(6):1517-28. PubMed ID: 17395559
[TBL] [Abstract][Full Text] [Related]
6. Lithocholic acid can carry out in vivo functions of vitamin D.
Nehring JA; Zierold C; DeLuca HF
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10006-9. PubMed ID: 17535892
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of vitamin D receptor-mediated activities of cholesterol and vitamin D metabolites.
Teske KA; Bogart JW; Sanchez LM; Yu OB; Preston JV; Cook JM; Silvaggi NR; Bikle DD; Arnold LA
Eur J Med Chem; 2016 Feb; 109():238-46. PubMed ID: 26774929
[TBL] [Abstract][Full Text] [Related]
8. Lithocholate--a promising non-calcaemic calcitriol surrogate for promoting human osteoblast maturation upon biomaterials.
Mansell JP; Shorez D; Farrar D; Nowghani M
Steroids; 2009 Nov; 74(12):963-70. PubMed ID: 19646460
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
10. Normal and osteoporotic human osteoblast behaviour after 1,25-dihydroxy-vitamin D(3) stimulation.
Maruotti N; Corrado A; Grano M; Colucci S; Cantatore FP
Rheumatol Int; 2009 Apr; 29(6):667-72. PubMed ID: 18989673
[TBL] [Abstract][Full Text] [Related]
11. Lithocholic acid induction of the FGF19 promoter in intestinal cells is mediated by PXR.
Wistuba W; Gnewuch C; Liebisch G; Schmitz G; Langmann T
World J Gastroenterol; 2007 Aug; 13(31):4230-5. PubMed ID: 17696253
[TBL] [Abstract][Full Text] [Related]
12. Zinc increases the activity of vitamin D-dependent promoters in osteoblasts.
Lutz W; Burritt MF; Nixon DE; Kao PC; Kumar R
Biochem Biophys Res Commun; 2000 Apr; 271(1):1-7. PubMed ID: 10777672
[TBL] [Abstract][Full Text] [Related]
13. RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis.
Giner M; Rios MA; Montoya MA; Vázquez MA; Naji L; Pérez-Cano R
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):46-51. PubMed ID: 19073256
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor as an intestinal bile acid sensor.
Makishima M; Lu TT; Xie W; Whitfield GK; Domoto H; Evans RM; Haussler MR; Mangelsdorf DJ
Science; 2002 May; 296(5571):1313-6. PubMed ID: 12016314
[TBL] [Abstract][Full Text] [Related]
16. Multiple levels of steroid hormone-dependent control of osteocalcin during osteoblast differentiation: glucocorticoid regulation of basal and vitamin D stimulated gene expression.
Shalhoub V; Aslam F; Breen E; van Wijnen A; Bortell R; Stein GS; Stein JL; Lian JB
J Cell Biochem; 1998 May; 69(2):154-68. PubMed ID: 9548563
[TBL] [Abstract][Full Text] [Related]
17. Neridronate and human osteoblasts in normal, osteoporotic and osteoarthritic subjects.
Corrado A; Cantatore FP; Grano M; Colucci S
Clin Rheumatol; 2005 Sep; 24(5):527-34. PubMed ID: 16091841
[TBL] [Abstract][Full Text] [Related]
18. Effects of glucocorticoids on vitamin D
Zayny A; Almokhtar M; Wikvall K; Ljunggren Ö; Ubhayasekera K; Bergquist J; Kibar P; Norlin M
Mol Cell Endocrinol; 2019 Oct; 496():110525. PubMed ID: 31352041
[TBL] [Abstract][Full Text] [Related]
19. Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia.
Ishizawa M; Matsunawa M; Adachi R; Uno S; Ikeda K; Masuno H; Shimizu M; Iwasaki K; Yamada S; Makishima M
J Lipid Res; 2008 Apr; 49(4):763-72. PubMed ID: 18180267
[TBL] [Abstract][Full Text] [Related]
20. Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative farnesoid X receptor response element.
Lu Y; Heydel JM; Li X; Bratton S; Lindblom T; Radominska-Pandya A
Drug Metab Dispos; 2005 Jul; 33(7):937-46. PubMed ID: 15821044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
